Predictions
Thomson Reuters Corp.
Start price
Target price
Perf. (%)
€158.00
08.06.24
08.06.24
-
08.06.25
08.06.25
-1.90%
22.06.24
22.06.24
Transmedics Group Inc
Start price
Target price
Perf. (%)
€127.05
07.06.24
07.06.24
€161.96
07.06.25
07.06.25
5.39%
08:11
08:11
Cannovum Cannabis AG
Start price
Target price
Perf. (%)
€2.26
07.06.24
07.06.24
-
07.06.25
07.06.25
0.00%
09.06.24
09.06.24
Probably not worthwhile Investment
Transmedics Group Inc
Start price
Target price
Perf. (%)
€126.00
06.06.24
06.06.24
€147.78
06.06.25
06.06.25
6.27%
08:11
08:11
Metasphere Labs Inc.
Start price
Target price
Perf. (%)
€1.10
06.06.24
06.06.24
-
06.06.25
06.06.25
59.55%
08.06.24
08.06.24
Could be worthwhile Investment >10% per year
Transmedics Group Inc
Start price
Target price
Perf. (%)
€120.35
04.06.24
04.06.24
€138.95
04.06.25
04.06.25
13.38%
08:11
08:11
Affimed N.v.
Start price
Target price
Perf. (%)
€6.32
03.06.24
03.06.24
-
03.06.25
03.06.25
-11.08%
09.06.24
09.06.24
Probably not worthwhile Investment
Affimed N.v.
Start price
Target price
Perf. (%)
€6.00
03.06.24
03.06.24
-
03.06.25
03.06.25
-22.50%
09:30
09:30
Good culture
Capable Management
Could be worthwhile Investment >10% per year
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€18.54
03.06.24
03.06.24
€20.28
03.06.25
03.06.25
17.56%
11:18
11:18
Affimed N.v.
Start price
Target price
Perf. (%)
€4.19
03.06.24
03.06.24
-
03.06.25
03.06.25
81.38%
03.06.24
03.06.24
Could be worthwhile Investment >10% per year
Amc Entertainment Holdings Inc
Start price
Target price
Perf. (%)
€5.10
03.06.24
03.06.24
-
03.06.25
03.06.25
-13.84%
03.06.24
03.06.24
Could be worthwhile Investment >10% per year
Capable Management
Good culture
No Innovation
Amc Entertainment Holdings Inc
Start price
Target price
Perf. (%)
€4.75
03.06.24
03.06.24
-
03.06.25
03.06.25
-7.38%
03.06.24
03.06.24
Probably not worthwhile Investment
Americas Gold & Silver Corp.
Start price
Target price
Perf. (%)
€0.32
03.06.24
03.06.24
-
03.06.25
03.06.25
-28.89%
25.07.24
25.07.24
Could be very worthwhile Investment >20% year
Future proof or reliable business model
Revenue growth >5% per year expected
Innovative
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.34
01.06.24
01.06.24
-
01.06.25
01.06.25
-38.03%
25.07.24
25.07.24